当前位置:首页 - 行情中心 - 柳药集团(603368) - 财务分析

柳药集团

(603368)

  

流通市值:75.74亿  总市值:75.74亿
流通股本:3.97亿   总股本:3.97亿

柳药集团(603368)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润4.38亿元,每股收益1.08元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益807857.18万元,未分配利润465032.45万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产2116342.56万元,负债1308485.39万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入10,300,787,773.835,316,977,105.5921,182,454,178.2615,992,976,622.19
营业总成本9,788,688,628.194,972,816,882.8320,166,805,761.415,081,535,497.52
其他经营收益
营业利润505,036,476.16310,004,220.411,003,597,977.92854,881,320.44
利润总额499,039,943.11310,542,609.371,003,136,182.84856,674,090.04
净利润438,387,532.04277,690,407.78867,534,387.56745,538,643.11
每股收益
其他综合收益----
综合收益总额438,387,532.04277,690,407.78867,534,387.56745,538,643.11
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计18,485,169,091.0418,382,050,280.3318,613,126,636.7819,488,514,176.24
非流动资产:
非流动资产合计2,678,256,522.092,614,786,105.42,655,819,603.972,544,513,341
资产总计21,163,425,613.1320,996,836,385.7321,268,946,240.7522,033,027,517.24
流动负债:
流动负债合计11,367,199,123.7611,219,370,266.0211,857,710,679.0212,182,024,380.53
非流动负债:
非流动负债合计1,717,654,733.661,561,266,460.661,474,312,987.321,584,789,881.33
负债合计13,084,853,857.4212,780,636,726.6813,332,023,666.3413,766,814,261.86
所有者权益(或股东权益):
归属于母公司股东权益合计7,756,951,998.177,903,330,365.097,624,408,552.377,792,074,829.18
股东权益合计8,078,571,755.718,216,199,659.057,936,922,574.418,266,213,255.38
负债和股东权益合计21,163,425,613.1320,996,836,385.7321,268,946,240.7522,033,027,517.24
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计12,240,812,179.585,475,410,034.9725,331,777,913.6316,415,860,223.01
经营活动现金流出小计12,152,378,764.215,993,001,818.4924,493,265,036.5216,292,880,592.8
经营活动产生的现金流量净额88,433,415.37-517,591,783.52838,512,877.11122,979,630.21
投资活动产生的现金流量:
投资活动现金流入小计488,285,390.21322,442,848.21,314,390,658.45243,209,779.14
投资活动现金流出小计803,858,179.46290,139,483.911,456,732,727.02348,767,895.92
投资活动产生的现金流量净额-315,572,789.2532,303,364.29-142,342,068.57-105,558,116.78
筹资活动产生的现金流量:
筹资活动现金流入小计2,353,449,673.711,486,857,044.826,953,066,397.075,261,485,698.29
筹资活动现金流出小计3,378,668,206.712,274,659,892.876,899,625,374.746,045,639,301.15
筹资活动产生的现金流量净额-1,025,218,533-787,802,848.0553,441,022.33-784,153,602.86
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-1,252,357,906.88-1,273,091,267.28749,611,830.87-766,732,089.43
期末现金及现金等价物余额2,146,203,157.342,125,403,507.853,398,561,064.221,882,217,143.92
补充资料:
现金及现金等价物的净增加额-1,252,357,906.88-749,611,830.87-
最新报告期:2025-08-29
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华泰证券代雯,孔垂岩,王殷杰2.142.242.322025-08-29
TOP↑